Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome
Abstract POEMS syndrome is a rareparaneoplastic disorder driven by an underlying low level plasma cell dyscrasiaand associated with elevated serum vascular endothelial growth factor (VEGF). Dueto its rarity, there are no internationally agreed standards of care, with verylimited data to guide manage...
| Published in: | eJHaem |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-08-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jha2.492 |